• AIDS Treatment News
• AIDS Treatment Data Network
• www.hcvadvocate.org
• Test Positive Aware Network (TPAN)
• Clinical Care Options - HIV, Hepatitis and Oncology
• www.HIVandHepatitis. com
• Project Inform
• Treatment Action Group (TAG)
• www. AIDSMEDS.com
• www.NATAP.org

News Briefs

FDA has granted accelerated approval for a new anti-HIV drug. The drug, Intelence (also known as etravirine or TMC-125) was approved based on two trials conducted mostly in men who had very few HIV treatment options. Over 3000 people have also received the drug through an Expanded Access Program. The links below are for several press releases, including one from the FDA, Tibotec (the makers of the drug), and The Fair Pricing Coalition. The FDA approved label for the drug is included as well. In addition, there is a press release by The Fair Pricing Coalition on a stunning increase in the price of Atripla and other drugs made by BMS.

• FDA notice about Intelence approval


• The Fair Pricing Coalition commends Tibotec and parent company leadership


• Tibotec Press Release about Intelence (etravirine), including positive comments regarding Intelence pricing from The Fair Pricing Coalition


• Patient Information on Intelence (etravirine) from the FDA


• The FDA approved, entire label for Intelence (etravirine)

HIV and Hepatitis C Meeting in New York City. January 25, 2008. Please download the agenda and form to register. Limited space! Check it out now.

The first ever integrase inhibitor for the treatment of HIV disease was approved.

States are continually being updated with information on HIV and Hepatitis services and treatments through The Access Project.

New HIV Treatment Guidelines have been released, along with Fact Sheets in English and Spanish. An important article was published in Hepatology, Vol.46, No.6, 2007 that highlights a meeting of the Antiviral Products Advisory Committee that discussed the development and approval of treatments for hepatitis C (HCV). Full transcripts of the meeting are available to the public.

Find out all about advocacy and activism on Ryan White/ADAP, Medicaid and ETHA and a new group, Hep C Advocates UNITED ! at the newly redesigned website of Project Inform . The December 2007 version of Medicaid Watch is now available for download in PDF format. The first ever integrase inhibitor for the treatment of HIV disease was approved.

Monogram Biosciences and Pfizer, the makers of the newly approved drug Selzentry (maraviroc), released the results of tests that showed that the Trofile assay is much more reliable and specific than the SensiTrop assay. Until further studies are conducted Pfizer suggests that the Trofile test be used to determine CCR5 tropism if you are considering taking the drug Selzentry.

The drug fosamprenavir (Lexiva) was approved as a once a day treatment for protease inhibitor naive individuals. Ritonavir (100mg) is taken with 1400 mg fosamprenavir. GSK's abacavir and Epzicom HLA-B*5701 allele findings prompt a survey study - GSK is conducting a study called TEACH (The Evaluation of Attitudes and practice patterns of HIV clinicians when Considering the use of HLA-B*5701 in clinical practice) that will document the experiences of US-based HIV clinicians using this pharmacogenetic test. Any US-based clinician may register at the study website. Discuss all treatment options and decisions with qualified medical professionals who know your health history.

Case Management and Support Services : Find case management services, health care provider, or a network of service providers and community based organizations in a state

HIV Treatments : Listings of Treatments for people with AIDS and HIV related conditions, including preventive therapies and links to more information. New treatments are added as they are approved by the FDA.

Hepatitis Treatments and Vaccines : Listings of hepatitis vaccinations, immunizations, and treatments for Hepatitis C and Hepatitis B. This includes currently approved treatments and drugs in development.

Patient Assistance and Expanded Access Programs : Drugs available through Expanded Access and Patient Assistance Programs, including HIV and Hepatitis treatments and vaccines.

Educational and Informational Resources : A library of fact sheets, reports, training resources and internet links to inform, educate, and encourage collaboration and networking among communities and providers.

Simple Facts Sheets : Fact sheets on HIV and Hepatitis treatments, conditions, symptoms, research studies, and other topics. The purpose of The Simple Facts Sheets are to take complicated subjects and make them accessible.